ClinicalTrials.Veeva

Menu

Nephroprotective Effect of Nicorandil in Type 2 Diabetes Mellitus

T

Tanta University

Status and phase

Enrolling
Phase 3

Conditions

Type2 Diabetes Mellitus

Treatments

Drug: Nicorandil 10 MG Oral Tablet

Study type

Interventional

Funder types

Other

Identifiers

NCT06430125
Nicorandil Nephroprotective

Details and patient eligibility

About

This study aims to evaluate the possible nephroprotective effect of nicorandil in patients with type 2 diabetes mellitus .

Enrollment

46 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients newly diagnosed with T2DM with diet control and good glycemic index ( Hb A1C< 7 )
  • Age range between 18 and 60 years old.
  • Both sexes.
  • Stage 1and Stage 2 CKD according to KDIGO .
  • Controlled HTN .

Exclusion criteria

  • Pregnant and lactating females.
  • Patients with hypersensitivity to nicorandil.
  • Other Causes of CKD or Nephropathy eg : Uncontrolled HTN , Renal Malignancy , collagen disease as Amyloidosis and some autoimmune disease as ( SLE and Rh.fever ) .
  • Uncontrolled HTN and its antihypertensive medications ( ACEI , ARB ) and other antihypertensive medications .
  • Patients receiving nephrotoxic drugs as aminoglycosides, non-steroidal anti inflammatory drugs and contrast media.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

46 participants in 2 patient groups

Control group
No Intervention group
Description:
this group will include 23 patients who will receive metformin 2gm/day. The initial dose of metformin will be 1 g/day taken orally with the meal. After 7 days (week 1), the dose will be up titrated to daily dose of 2,000 mg/day. Treatment duration will be 12 weeks .
Nicorandil group
Active Comparator group
Description:
this group will include 23 patients who will receive a combination of metformin 2g/day and nicorandil 10 mg twice daily. The initial dose of metformin will be 1 g/day taken orally with the meal. After 7 days (week 1), the dose will be uptitrated to daily dose of 2,000 mg/day. Treatment duration will be 12 weeks .
Treatment:
Drug: Nicorandil 10 MG Oral Tablet

Trial contacts and locations

1

Loading...

Central trial contact

Mohammed A El-hazzab

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems